| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/23/2009 | WO2007032804A3 Novel uses for anti-ige therapy |
| 04/23/2009 | WO2007019426A3 A novel peptide involved in energy homeostasis |
| 04/23/2009 | WO2007013997A3 Inhibition of the raf/mek/p-erk pathway for treating cancer |
| 04/23/2009 | WO2007005786A3 Methods and compositions with enhanced therapeutic activity |
| 04/23/2009 | WO2006135886A3 Compositions and methods for treating and diagnosing cancer |
| 04/23/2009 | WO2006107387A3 Wound treatment device for photodynamic therapy and method of using same |
| 04/23/2009 | WO2006076467A3 Treatment of pre-eclampsia in pregnant women using targeted apheresis |
| 04/23/2009 | WO2006071843A3 Biomarkers for breast cancer |
| 04/23/2009 | WO2006031583A3 Methods and compositions for measuring canine bnp and uses thereof |
| 04/23/2009 | WO2005121179A3 Transferrin receptor antibodies |
| 04/23/2009 | WO2004028479A9 Nouvelles compositions et methodes de traitement du psoriasis |
| 04/23/2009 | US20090105461 Calicheamicin conjugates |
| 04/23/2009 | US20090105460 Antibody and inhibitor, and transfection method or kit using them |
| 04/23/2009 | US20090105459 Novel hemopoietin receptor protein, nr12 |
| 04/23/2009 | US20090105458 Novel hemopoietin receptor protein, nr12 |
| 04/23/2009 | US20090105457 Novel hemopoietin receptor protein, nr12 |
| 04/23/2009 | US20090105347 Thyronamine derivatives and analogs and methods of use thereof |
| 04/23/2009 | US20090105122 Selective neuropeptide y2 receptor agonists |
| 04/23/2009 | US20090105086 Methods of selecting internalizing antibodies |
| 04/23/2009 | US20090105083 Ligand Screening and Discovery |
| 04/23/2009 | US20090104703 Nucleic Acids Encoding Proteins Involved in Sensory Transduction |
| 04/23/2009 | US20090104693 a gene encoding the blood group Pk (Gb3) synthase, termed alpha 4Gal-T1, probes to the DNA encoding alpha 4Gal-T1, DNA constructs comprising DNA encoding alpha 4Gal-T1 |
| 04/23/2009 | US20090104684 Diagnosis of carcinomas |
| 04/23/2009 | US20090104670 N-carbobenzyloxy (N-CBZ)-deprotecting enzyme and uses therefor |
| 04/23/2009 | US20090104662 Use of interleukin-4 antagonists and compositions thereof |
| 04/23/2009 | US20090104660 Expression vector for secreting antibody fragment using e. coli signal sequence and method for mass-producing antibody fragment |
| 04/23/2009 | US20090104646 Generating preferential immunoglobulins in hypermutable cells for use as tools in antibody-dependent cellular cytotoxicity; immunotherapy; useful for generating antibody-producing cells with increased level of antibody production |
| 04/23/2009 | US20090104631 Psca: prostate stem cell antigen and uses thereof |
| 04/23/2009 | US20090104628 Method for quantifying phosphokinase activity on proteins |
| 04/23/2009 | US20090104623 Compositions for controlling hair growth |
| 04/23/2009 | US20090104622 Extracellular/Epidermal Growth Factor Like Protein |
| 04/23/2009 | US20090104619 Human G-Protein Coupled Receptors |
| 04/23/2009 | US20090104279 Use of pak inhibitor for the treatment of a joint disease |
| 04/23/2009 | US20090104232 Yersina virulence antigen specific monoclonal antibody for use in prevention of plague; prevention of bioterrorism; directed protein evolution |
| 04/23/2009 | US20090104218 Group B Streptococcus |
| 04/23/2009 | US20090104215 Methods and compositions for modulating tumor cell activity |
| 04/23/2009 | US20090104208 House Dust Mite Allergen |
| 04/23/2009 | US20090104207 Hepatitis C Virus Neutralizing Antibodies |
| 04/23/2009 | US20090104205 Human-Murine Chimeric Antibodies Against Respiratory Syncytial Virus |
| 04/23/2009 | US20090104204 Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof |
| 04/23/2009 | US20090104203 Compositions and Methods for Regulating Osteoclast Differentiation, Activation and Bone Resorption |
| 04/23/2009 | US20090104202 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases |
| 04/23/2009 | US20090104199 Breast Cancer Resistance Protein (BCRP) And The DNA Which Encodes It |
| 04/23/2009 | US20090104198 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 04/23/2009 | US20090104196 for modulating the activity of the lysine-specific demethylase (LSD1) in a mammal; for identifying a patient having high risk prostate carcinomas |
| 04/23/2009 | US20090104195 Targeted ligands |
| 04/23/2009 | US20090104192 Monoclonal Antibodies to Hepatocyte Growth Factor |
| 04/23/2009 | US20090104191 Prevention of tumors with monoclonal antibodies against neu |
| 04/23/2009 | US20090104190 Humanized anti-cd4 antibody with immunosuppressive properties |
| 04/23/2009 | US20090104189 Neutrokine-alpha and neutrokine-alpha splice variant |
| 04/23/2009 | US20090104188 Anti-hepatitis c virus antibody and uses thereof |
| 04/23/2009 | US20090104187 Novel Rabbit Antibody Humanization Methods and Humanized Rabbit Antibodies |
| 04/23/2009 | US20090104186 Melanoma-associated MHC class I associated oligopeptides and the uses thereof |
| 04/23/2009 | US20090104185 Methods and Compositions for Mycoplasma Toxins |
| 04/23/2009 | US20090104182 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 04/23/2009 | US20090104181 Antibodies for Discrimination of Prions |
| 04/23/2009 | US20090104180 Using selectin/immunoglobulin fusion for quelling organ transplant rejection |
| 04/23/2009 | US20090104177 Peptides for inhibiting the interaction of protein kinase a and protein kinase a anchor proteins |
| 04/23/2009 | US20090104150 Polymer conjugates of interferon Beta-1a and uses |
| 04/23/2009 | US20090104147 Sialoadhesin-Related Compositions and Methods |
| 04/23/2009 | US20090104115 Cancerous disease modifying antibodies |
| 04/23/2009 | CA2734173A1 Igm-mediated receptor clustering and cell modulation |
| 04/23/2009 | CA2703050A1 Anti-amyloid antibodies, compositions, methods and uses |
| 04/23/2009 | CA2702939A1 Anti-bst2 antibody |
| 04/23/2009 | CA2702880A1 Antibody capable of specifically binding to a beta oligomer, and use thereof |
| 04/23/2009 | CA2702686A1 Translocation and mutant ros kinase in human non-small cell lung carcinoma |
| 04/23/2009 | CA2702617A1 Immunotherapy regimes dependent on apoe status |
| 04/23/2009 | CA2702612A1 Antibodies that bind to mammalian ngal and uses thereof |
| 04/23/2009 | CA2702611A1 Immunoassays and kits for the detection of ngal |
| 04/23/2009 | CA2702582A1 Feline pancreatic lipase |
| 04/23/2009 | CA2702555A1 Cd19 binding agents and uses thereof |
| 04/23/2009 | CA2702473A1 Antibodies that bind il-4 and/or il-13 and their uses |
| 04/23/2009 | CA2701338A1 Method for production of antibody |
| 04/23/2009 | CA2701329A1 Combination of blys inhibition and anti-cd 20 agents for treatment of autoimmune disease |
| 04/23/2009 | CA2698541A1 Cysteine engineered anti-tenb2 antibodies and antibody drug conjugates |
| 04/22/2009 | EP2050765A1 Methods for use in human-adapting monoclonal antibodies |
| 04/22/2009 | EP2050764A1 Novel polyvalent bispecific antibody format and uses thereof |
| 04/22/2009 | EP2050762A2 Novel polypeptides and nucleic acids encoding the same |
| 04/22/2009 | EP2050464A2 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
| 04/22/2009 | EP2050335A1 Gene disruptions, compositions and methods relating thereto |
| 04/22/2009 | EP2049893A2 Bmp-1 procollagen c-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders |
| 04/22/2009 | EP2049660A2 Novel glutamic acid decarboxylase (gad) proteins and methods of use |
| 04/22/2009 | EP2049571A2 Targeted binding agents directed to pdgfr-alpha and uses thereof |
| 04/22/2009 | EP2049570A2 Purification of a bivalently active antibody using a non-chromatographic method |
| 04/22/2009 | EP2049569A2 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 04/22/2009 | EP2049567A2 Human glp-1 mimetibodies, compositions, methods and uses |
| 04/22/2009 | EP1587476A4 Novel compositions and methods in cancer |
| 04/22/2009 | EP1466623B1 Anti-fgf-8 antibodies against arthritis |
| 04/22/2009 | EP1392719B1 Forms of prostate specific antigens and methods for their detection |
| 04/22/2009 | EP1379873B1 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 04/22/2009 | EP1200126B1 Use of cd28 specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections |
| 04/22/2009 | EP1190101B1 Compositions and methods for preventing transepithelial transmission of hiv |
| 04/22/2009 | EP1181319B1 Chimeric dr4 antibodies and uses thereof |
| 04/22/2009 | EP1090039B1 Peptide composition as immunogen for the treatment of allergy |
| 04/22/2009 | EP0882067B2 Methods of treating vascular disease with tnf antagonists |
| 04/22/2009 | EP0842948B1 ANTIFas LIGAND ANTIBODIES AND ASSAY METHOD BY USING THE SAME |
| 04/22/2009 | EP0736106B2 Methods of screening for beta-amyloid peptide production inhibitors |
| 04/22/2009 | EP0635068B2 Amplification of human mdm2 gene in human tumors |
| 04/22/2009 | CN101416061A Method for the detection and/or enrichment of analyte proteins and/or analyte peptides from a complex protein mixture |
| 04/22/2009 | CN101415730A Compositions and methods of use for antibodies of c-Met |